With over a decade of groundbreaking innovative solutions in Vietnam's pharmaceutical sector, Takeda has been recognised for its contribution to sustainable development.

At the VIR health conference- "Empowering health innovation for sustainability vision" held on September 25, 2024, Dion Warren – area head of India and Southeast Asia (I-SEA) of Takeda, emphasised Takeda's commitment in delivering transformative healthcare solutions for lasting social value.

For over 10 years, Takeda has been a dedicated healthcare partner in Vietnam, delivering transformative treatments and contributing significant value to public health. The recent approval of its dengue vaccine further strengthens this commitment. Dion Warren, Takeda’s area head for India and Southeast Asia, talked to VIR’s Bich Thuy about the company’s journey and its plans to bring more innovative medicines to Vietnam.

This year's Rare Disease Day, February 29, served as a momentous occasion to celebrate the extraordinary journeys of rare disease patients and their devoted caregivers. Having established a strong presence in the Vietnamese market over many years, Takeda holds steadfast in its commitment to bolstering the wellbeing of the Vietnamese people, especially those afflicted by rare diseases. Than Trong Son, head of Medical Affairs, Takeda Vietnam, delves into Takeda's tireless endeavours and commitment to supporting patients afflicted by rare diseases in the country.

The Pasteur Institute in Ho Chi Minh City joined hands with Takeda Vietnam to host a workshop on Innovating and enhancing the effectiveness of dengue prevention and control for public health on September 23.

Takeda Vietnam has prevailed over thousands of organisations to win the Best Workplace in Asia 2022 award by Great Place to Work, the global authority on workplace culture.

Takeda Vietnam was recognised as one of Vietnam’s best workplaces in 2022 by Great Place to Work® ASEAN & ANZ, the global organisation on workplace culture.

Takeda Vietnam is demonstrating its commitment to protecting the planet through the planting of more than 500 trees in Can Gio Biosphere Reserve, located about 50km from Ho Chi Minh City.

Over the past few years, Vietnam has placed more focus on rare diseases and enhanced rare disease capabilities in diagnosis, treatment, and management guidelines for some rare diseases. To advance this progress, the Vietnamese Ministry of Health has explored collaborating in public-private partnerships with various stakeholders such as pharmaceutical companies. Katharina Geppert, country manager of Takeda Vietnam, talked with VIR about their contributions to rare diseases in Vietnam.

The Drug Administration of Vietnam (DAV) on May 14 issued a decision approving dengue vaccine of Takeda Pharmaceutical Company Limited, becoming the first dengue vaccine approved in the country for use in individuals from four years of age, regardless of previous dengue exposure and without the need for pre-vaccination testing.

The Japanese Embassy in Vietnam will organize calligraphy demonstration and workshop entitled “The Power of Calligraphy” from Takeda Souun at Temple of Literature in Hanoi at 10 a.m. on Saturday.